{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T16:43:28Z","timestamp":1790700208704,"version":"4.1.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,18]],"date-time":"2024-07-18T00:00:00Z","timestamp":1721260800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007436","name":"Erling Persson Family Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007436","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["iScience"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.isci.2024.110564","type":"journal-article","created":{"date-parts":[[2024,7,23]],"date-time":"2024-07-23T03:06:55Z","timestamp":1721704015000},"page":"110564","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Serum protein biomarker profile distinguishes acetylcholine receptor antibody seropositive myasthenia gravis patients from healthy controls"],"prefix":"10.1016","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7116-0939","authenticated-orcid":false,"given":"Amol K.","family":"Bhandage","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viktorija","family":"Kenina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-2617-2083","authenticated-orcid":false,"given":"Yu-Fang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9416-1600","authenticated-orcid":false,"given":"Marija","family":"Roddate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4333-6682","authenticated-orcid":false,"given":"Gundega","family":"Kauke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arta","family":"Grosmane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Violeta","family":"\u017dukova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2152-4343","authenticated-orcid":false,"given":"Niclas","family":"Eriksson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-4234-8814","authenticated-orcid":false,"given":"Katja","family":"Gabrysch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanel","family":"Punga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2178-9413","authenticated-orcid":false,"given":"Anna Rostedt","family":"Punga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.isci.2024.110564_bib1","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/S1474-4422(21)00297-0","article-title":"Epidemiology, diagnostics, and biomarkers of autoimmune neuromuscular junction disorders","volume":"21","author":"Punga","year":"2022","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.isci.2024.110564_bib2","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.autrev.2013.03.007","article-title":"The different roles of the thymus in the pathogenesis of the various myasthenia gravis subtypes","volume":"12","author":"Marx","year":"2013","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.isci.2024.110564_bib3","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/nrneurol.2016.44","article-title":"Myasthenia gravis - autoantibody characteristics and their implications for therapy","volume":"12","author":"Gilhus","year":"2016","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.isci.2024.110564_bib4","doi-asserted-by":"crossref","DOI":"10.1038\/srep25886","article-title":"Changes in inflammatory cytokine networks in myasthenia gravis","volume":"6","author":"Uzawa","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.isci.2024.110564_bib5","doi-asserted-by":"crossref","DOI":"10.1038\/srep39716","article-title":"Profile of upregulated inflammatory proteins in sera of Myasthenia Gravis patients","volume":"7","author":"Molin","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.isci.2024.110564_bib6","doi-asserted-by":"crossref","DOI":"10.3390\/cells11040740","article-title":"Towards Personalized Medicine in Myasthenia Gravis: Role of Circulating microRNAs miR-30e-5p, miR-150-5p and miR-21-5p","volume":"11","author":"Beretta","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.isci.2024.110564_bib7","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1002\/acn3.24","article-title":"Circulating miRNAs in myasthenia gravis: miR-150-5p as a new potential biomarker","volume":"1","author":"Punga","year":"2014","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.isci.2024.110564_bib8","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.jneuroim.2018.05.003","article-title":"Circulating microRNA miR-21-5p, miR-150-5p and miR-30e-5p correlate with clinical status in late onset myasthenia gravis","volume":"321","author":"Sabre","year":"2018","journal-title":"J.\u00a0Neuroimmunol."},{"key":"10.1016\/j.isci.2024.110564_bib9","doi-asserted-by":"crossref","first-page":"213","DOI":"10.3389\/fimmu.2020.00213","article-title":"Circulating miRNAs as Potential Biomarkers in Myasthenia Gravis: Tools for Personalized Medicine","volume":"11","author":"Sabre","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.isci.2024.110564_bib10","doi-asserted-by":"crossref","DOI":"10.3390\/cells12202456","article-title":"Current Biomarker Strategies in Autoimmune Neuromuscular Diseases","volume":"12","author":"Oeztuerk","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.isci.2024.110564_bib11","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1111\/ene.15565","article-title":"Role of autoantibody levels as biomarkers in the management of patients with myasthenia gravis: A systematic review and expert appraisal","volume":"30","author":"Meisel","year":"2023","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.isci.2024.110564_bib12","doi-asserted-by":"crossref","first-page":"2901","DOI":"10.3389\/fimmu.2018.02901","article-title":"Th22 Cells Promote Osteoclast Differentiation via Production of IL-22 in Rheumatoid Arthritis","volume":"9","author":"Miyazaki","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.isci.2024.110564_bib13","doi-asserted-by":"crossref","first-page":"5324","DOI":"10.4049\/jimmunol.174.9.5324","article-title":"Overexpression of IFN-induced protein 10 and its receptor CXCR3 in myasthenia gravis","volume":"174","author":"Feferman","year":"2005","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.isci.2024.110564_bib14","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1016\/j.jid.2021.10.028","article-title":"The Contribution of LIGHT (TNFSF14) to the Development of Systemic Sclerosis by Modulating IL-6 and T Helper Type 1 Chemokine Expression in Dermal Fibroblasts","volume":"142","author":"Ikawa","year":"2022","journal-title":"J.\u00a0Invest. Dermatol."},{"key":"10.1016\/j.isci.2024.110564_bib15","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1177\/1352458512463766","article-title":"Serum levels of LIGHT in MS","volume":"19","author":"Malmestrom","year":"2013","journal-title":"Mult. Scler."},{"key":"10.1016\/j.isci.2024.110564_bib16","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1007\/s00401-021-02299-y","article-title":"Single-cell profiling of myasthenia gravis identifies a pathogenic T\u00a0cell signature","volume":"141","author":"Ingelfinger","year":"2021","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.isci.2024.110564_bib17","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1111\/cei.12272","article-title":"Serum cytokine and chemokine profiles in patients with myasthenia gravis","volume":"176","author":"Uzawa","year":"2014","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.isci.2024.110564_bib18","doi-asserted-by":"crossref","DOI":"10.1080\/22221751.2022.2150566","article-title":"Distinct inflammation-related proteins associated with T\u00a0cell immune recovery during chronic HIV-1 infection","volume":"12","author":"Wan","year":"2023","journal-title":"Emerg. Microb. Infect."},{"key":"10.1016\/j.isci.2024.110564_bib19","doi-asserted-by":"crossref","DOI":"10.1186\/ar3431","article-title":"Increasing levels of circulating Th17 cells and interleukin-17 in rheumatoid arthritis patients with an inadequate response to anti-TNF-alpha therapy","volume":"13","author":"Chen","year":"2011","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.isci.2024.110564_bib20","doi-asserted-by":"crossref","first-page":"539","DOI":"10.3389\/fimmu.2019.00539","article-title":"Causes and Consequences of miR-150-5p Dysregulation in Myasthenia Gravis","volume":"10","author":"Cron","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.isci.2024.110564_bib21","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1080\/01616412.2018.1525121","article-title":"Clinical differences of early and late-onset myasthenia gravis in 985 patients","volume":"41","author":"Fan","year":"2019","journal-title":"Neurol. Res."},{"key":"10.1016\/j.isci.2024.110564_bib22","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/j.autrev.2016.07.007","article-title":"Revisiting the regulatory roles of the TGF-beta family of cytokines","volume":"15","author":"Fujio","year":"2016","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.isci.2024.110564_bib23","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1002\/jcb.24792","article-title":"Effect of age on regulation of human osteoclast differentiation","volume":"115","author":"Chung","year":"2014","journal-title":"J.\u00a0Cell. Biochem."},{"key":"10.1016\/j.isci.2024.110564_bib24","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.jaut.2013.12.006","article-title":"Late-onset myasthenia gravis - CTLA4(low) genotype association and low-for-age thymic output of naive T\u00a0cells","volume":"52","author":"Chuang","year":"2014","journal-title":"J.\u00a0Autoimmun."},{"key":"10.1016\/j.isci.2024.110564_bib25","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1111\/ene.13535","article-title":"A nationwide epidemiological study of myasthenia gravis in Latvia","volume":"25","author":"Zieda","year":"2018","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.isci.2024.110564_bib26","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0095192","article-title":"Homogenous 96-plex PEA immunoassay exhibiting high sensitivity, specificity, and excellent scalability","volume":"9","author":"Assarsson","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.isci.2024.110564_bib27","doi-asserted-by":"crossref","first-page":"20.10.1","DOI":"10.1002\/0471142727.mb2010s109","article-title":"Parallel protein detection by solid-phase proximity ligation assay with real-time PCR or sequencing","volume":"109","author":"Ebai","year":"2015","journal-title":"Curr. Protoc. Mol. Biol."},{"key":"10.1016\/j.isci.2024.110564_bib28","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/acn3.692","article-title":"miR-30e-5p as predictor of generalization in ocular myasthenia gravis","volume":"6","author":"Sabre","year":"2019","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.isci.2024.110564_bib29","doi-asserted-by":"crossref","DOI":"10.1126\/science.aav1741","article-title":"The biochemical basis of microRNA targeting efficacy","volume":"366","author":"McGeary","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.isci.2024.110564_bib30","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1213\/ANE.0000000000002864","article-title":"Correlation Coefficients: Appropriate Use and Interpretation","volume":"126","author":"Schober","year":"2018","journal-title":"Anesth. Analg."},{"key":"10.1016\/j.isci.2024.110564_bib31","first-page":"1","article-title":"Feature Selection with the Boruta Package","volume":"36","author":"Kursa","year":"2010","journal-title":"J.\u00a0Stat. Software"}],"container-title":["iScience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004224017899?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004224017899?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,12]],"date-time":"2024-11-12T11:25:53Z","timestamp":1731410753000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589004224017899"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":31,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["S2589004224017899"],"URL":"https:\/\/doi.org\/10.1016\/j.isci.2024.110564","relation":{},"ISSN":["2589-0042"],"issn-type":[{"value":"2589-0042","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Serum protein biomarker profile distinguishes acetylcholine receptor antibody seropositive myasthenia gravis patients from healthy controls","name":"articletitle","label":"Article Title"},{"value":"iScience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.isci.2024.110564","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"110564"}}